Centessa Pharmaceuticals
CNTA
CNTA was delisted on the 23rd of June, 2026.
80 hedge funds and large institutions have $781M invested in Centessa Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 19 reducing their positions, and 6 closing their positions.
341% more call options, than puts
Call options by funds: $119K | Put options by funds: $27K
183% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 6
42% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 19
16% more funds holding
Funds holding: 69 → 80 (+11)
0.33% more ownership
Funds ownership: 76.2% → 76.53% (+0.33%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
7% less capital invested
Capital invested by funds: $841M → $781M (-$59.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$16.9M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$15.4M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$9.96M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$9.37M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$8.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.7M |
| 2 |
ECM
ExodusPoint Capital Management
New York
|
-$2.77M |
| 3 |
Millennium Management
New York
|
-$2.26M |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$1.41M |
| 5 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$1.02M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Osaic Holdings
Scottsdale,
Arizona
| $3.67K | +$1.01K | +107 | +36% |
|
77
Daiwa Securities Group
Tokyo,
Japan
| $2K | – | – | – |
|
|
NS
78
NBC Securities
Birmingham,
Alabama
| $1K | – | – | – |
|
|
CSC
79
Caldwell Sutter Capital
Sausalito,
California
| $777 | – | – | – |
|
|
SWM
80
Spire Wealth Management
Mclean,
Virginia
| $632 | – | – | – |
|
|
81
Ensign Peak Advisors
Salt Lake City,
Utah
| – | -$1.41M | -125,157 | Closed |
|
|
LCM
82
Landscape Capital Management
Englewood,
New Jersey
| – | -$1.02M | -90,240 | Closed |
|
83
Goldman Sachs
New York
| – | -$622K | -55,027 | Closed |
|
84
Acadian Asset Management
Boston,
Massachusetts
| – | -$330K | -29,409 | Closed |
|
85
State of Tennessee, Department of Treasury
Nashville,
Tennessee
| – | -$65.5K | -5,798 | Closed |
|
|
AP
86
Advisors Preferred
Rockville,
Maryland
| – | -$20.2K | -1,825 | Closed |
|
CNTA Hedge Fund Activity: Q2 2024 in Review
80 of the 6,928 institutional investors tracked by Wall St. Rank reported a position in Centessa Pharmaceuticals (CNTA) for Q2 2024, worth a combined $781M — down 7.1% from $841M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new CNTA positions and 6 closed out — a net gain of 11 holders — while 27 added to existing stakes and 19 trimmed.
The largest buyer was First Light Asset Management, adding an estimated $16.9M. The largest seller was Point72 Asset Management, cutting an estimated $4.7M.
- 80 institutional investors held Centessa Pharmaceuticals (CNTA) as of Q2 2024, up from 69 in Q1 2024.
- Funds reported $781M of Centessa Pharmaceuticals stock for Q2 2024, down 7.1% quarter-over-quarter.
- 17 funds opened new Centessa Pharmaceuticals positions in Q2 2024 and 6 closed out, a net change of +11 holders.
- The largest Centessa Pharmaceuticals buyer in Q2 2024 was First Light Asset Management, an estimated $16.9M added.
- The largest Centessa Pharmaceuticals seller in Q2 2024 was Point72 Asset Management, an estimated $4.7M sold.
Based on aggregated 13F filings for Q2 2024.